These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18843028)

  • 1. Using mammographic density to improve breast cancer screening outcomes.
    Kavanagh AM; Byrnes GB; Nickson C; Cawson JN; Giles GG; Hopper JL; Gertig DM; English DR
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2818-24. PubMed ID: 18843028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
    Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program.
    Kirsh VA; Chiarelli AM; Edwards SA; O'Malley FP; Shumak RS; Yaffe MJ; Boyd NF
    J Natl Cancer Inst; 2011 Jun; 103(12):942-50. PubMed ID: 21540443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and tumor characteristics of interval cancers by mammographic density.
    Holm J; Humphreys K; Li J; Ploner A; Cheddad A; Eriksson M; Törnberg S; Hall P; Czene K
    J Clin Oncol; 2015 Mar; 33(9):1030-7. PubMed ID: 25646195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy, percent mammographic density, and sensitivity of mammography.
    Kavanagh AM; Cawson J; Byrnes GB; Giles GG; Marr G; Tong B; Gertig DM; Hopper JL
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1060-4. PubMed ID: 15894653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of five methods of measuring mammographic density: a case-control study.
    Astley SM; Harkness EF; Sergeant JC; Warwick J; Stavrinos P; Warren R; Wilson M; Beetles U; Gadde S; Lim Y; Jain A; Bundred S; Barr N; Reece V; Brentnall AR; Cuzick J; Howell T; Evans DG
    Breast Cancer Res; 2018 Feb; 20(1):10. PubMed ID: 29402289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of hormone therapy and risk of breast cancer detected at screening and between mammographic screens.
    Hofvind S; Møller B; Thoresen S; Ursin G
    Int J Cancer; 2006 Jun; 118(12):3112-7. PubMed ID: 16395702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study.
    Strand F; Humphreys K; Cheddad A; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
    Breast Cancer Res; 2016 Oct; 18(1):100. PubMed ID: 27716311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour size at detection according to different measures of mammographic breast density.
    Nickson C; Kavanagh AM
    J Med Screen; 2009; 16(3):140-6. PubMed ID: 19805755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammographic density as a surrogate marker for the effects of hormone therapy on risk of breast cancer.
    Boyd NF; Martin LJ; Li Q; Sun L; Chiarelli AM; Hislop G; Yaffe MJ; Minkin S
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):961-6. PubMed ID: 16702377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy and mammographic screening outcomes in Western Australia.
    Crouchley K; Wylie E; Khong E
    J Med Screen; 2006; 13(2):93-7. PubMed ID: 16792833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biennial versus annual mammography and the risk of late-stage breast cancer.
    White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
    J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are breast density and bone mineral density independent risk factors for breast cancer?
    Kerlikowske K; Shepherd J; Creasman J; Tice JA; Ziv E; Cummings SR
    J Natl Cancer Inst; 2005 Mar; 97(5):368-74. PubMed ID: 15741573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico.
    Rosenberg RD; Hunt WC; Williamson MR; Gilliland FD; Wiest PW; Kelsey CA; Key CR; Linver MN
    Radiology; 1998 Nov; 209(2):511-8. PubMed ID: 9807581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting interval and screen-detected breast cancers from mammographic density defined by different brightness thresholds.
    Nguyen TL; Aung YK; Li S; Trinh NH; Evans CF; Baglietto L; Krishnan K; Dite GS; Stone J; English DR; Song YM; Sung J; Jenkins MA; Southey MC; Giles GG; Hopper JL
    Breast Cancer Res; 2018 Dec; 20(1):152. PubMed ID: 30545395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
    Tamimi RM; Byrne C; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers.
    Mandelson MT; Oestreicher N; Porter PL; White D; Finder CA; Taplin SH; White E
    J Natl Cancer Inst; 2000 Jul; 92(13):1081-7. PubMed ID: 10880551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of hormone replacement therapy use on mammographic screening outcomes.
    Beckmann KR; Farshid G; Roder DM; Hiller JE; Lynch JW
    Cancer Causes Control; 2013 Jul; 24(7):1417-26. PubMed ID: 23649232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk.
    Kerlikowske K; Ichikawa L; Miglioretti DL; Buist DS; Vacek PM; Smith-Bindman R; Yankaskas B; Carney PA; Ballard-Barbash R;
    J Natl Cancer Inst; 2007 Mar; 99(5):386-95. PubMed ID: 17341730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AutoDensity: an automated method to measure mammographic breast density that predicts breast cancer risk and screening outcomes.
    Nickson C; Arzhaeva Y; Aitken Z; Elgindy T; Buckley M; Li M; English DR; Kavanagh AM
    Breast Cancer Res; 2013; 15(5):R80. PubMed ID: 24020331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.